CCR2 and neoplasm: In an attempt to study the distinguishable contribution of non-malignant CCR2+ cells at the tumor site to tumor development and angiogenesis, wild-type and CCR2−/− C57BL/6 mice were administrated with 7×106 CCR2+ TRAMP C1.luc cells that stably over-express a luciferase reporter gene.